News

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...
Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...
Pharmaceutical manufacturing giant Eli Lilly and Co. is exploring potential economic incentives for a $5.9B biomanufacturing ...
Eli Lilly has proposed investing $5.9 billion to build a pharmaceutical facility in Houston's Generation Park.
Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord ...
A major pharmaceutical manufacturing company is considering planting ground in Houston, with a $5.7 billion proposed ...
Lilly—a manufacturer of medicines like Mounjaro, Zepbound and Ebglyss—is considering purchasing 236 acres from Generation ...
Houston-based Empower Pharmacy has rapidly expanded over the past decade. Now a competitor is suing Empower, alleging its ...
HOUSTON — Eli Lilly & Co. (NYSE: LLY), one of the largest pharmaceutical manufacturers in the world, could be the latest major manufacturer moving into Houston. The Indianapolis-based drugmaker ...